NCT00220155View on ClinicalTrials.gov

Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

May 31, 2004

Conditions

Colorectal Cancer

Interventions

DRUG

Gemcitabine

Trial Locations (1)

SM2 5PT

Royal Marsden Hospital, Sutton

All Listed Sponsors

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT00220155 - Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter